BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29158900)

  • 21. Soluble urokinase plasminogen activator receptor informs on the progression course after multiple injuries.
    Patrani M; Tsaganos T; Kotzampassi K; Paraschos M; Katsenos C; Giamarellos-Bourboulis EJ; Mandragos K
    Biomarkers; 2016 Nov; 21(7):660-4. PubMed ID: 27121128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation.
    Madoiwa S; Nunomiya S; Ono T; Shintani Y; Ohmori T; Mimuro J; Sakata Y
    Int J Hematol; 2006 Dec; 84(5):398-405. PubMed ID: 17189219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationship between sepsis and 4G/5G polymorphism within the promoter region of plasminogen activator inhibitor-1 gene].
    Zhan ZY; Wang HW; Chen DF; Cheng BL; Wang HH; Fang XM
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(34):2404-7. PubMed ID: 16321247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical significance of circulating soluble RAGE in patients with severe sepsis.
    Matsumoto H; Matsumoto N; Ogura H; Shimazaki J; Yamakawa K; Yamamoto K; Shimazu T
    J Trauma Acute Care Surg; 2015 Jun; 78(6):1086-93; discussion 1093-4. PubMed ID: 26002402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis.
    Savva A; Raftogiannis M; Baziaka F; Routsi C; Antonopoulou A; Koutoukas P; Tsaganos T; Kotanidou A; Apostolidou E; Giamarellos-Bourboulis EJ; Dimopoulos G
    J Infect; 2011 Nov; 63(5):344-50. PubMed ID: 21839112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemostatic parameters in sepsis patients treated with anti-TNF alpha-monoclonal antibodies.
    Salat C; Boekstegers P; Holler E; Werdan K; Reinhardt B; Fateh-Moghadam S; Pihusch R; Kaul M; Beinert T; Hiller E
    Shock; 1996 Oct; 6(4):233-7. PubMed ID: 8902937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circadian Variation of Plasminogen-Activator-Inhibitor-1 Levels in Children with Meningococcal Sepsis.
    Boeddha NP; Driessen GJ; Cnossen MH; Hazelzet JA; Emonts M
    PLoS One; 2016; 11(11):e0167004. PubMed ID: 27893784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Host response biomarker in sepsis: suPAR detection.
    Giamarellos-Bourboulis EJ; Georgitsi M
    Methods Mol Biol; 2015; 1237():241-6. PubMed ID: 25319791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common TNF-alpha, IL-1 beta, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis.
    Jessen KM; Lindboe SB; Petersen AL; Eugen-Olsen J; Benfield T
    BMC Infect Dis; 2007 Sep; 7():108. PubMed ID: 17877801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome.
    Ware LB; Matthay MA; Parsons PE; Thompson BT; Januzzi JL; Eisner MD;
    Crit Care Med; 2007 Aug; 35(8):1821-8. PubMed ID: 17667242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic relevance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in gastric cancer.
    Ito H; Yonemura Y; Fujita H; Tsuchihara K; Kawamura T; Nojima N; Fujimura T; Nose H; Endo Y; Sasaki T
    Virchows Arch; 1996 Feb; 427(5):487-96. PubMed ID: 8624578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia.
    Geishofer G; Binder A; Müller M; Zöhrer B; Resch B; Müller W; Faber J; Finn A; Endler G; Mannhalter C; Zenz W;
    Eur J Pediatr; 2005 Aug; 164(8):486-90. PubMed ID: 15843979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis.
    Zeng M; Chang M; Zheng H; Li B; Chen Y; He W; Huang C
    Am J Emerg Med; 2016 Mar; 34(3):375-80. PubMed ID: 26615223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depressed plasma activity of plasminogen or alpha2 plasmin inhibitor is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation.
    Asakura H; Ontachi Y; Mizutani T; Kato M; Ito T; Saito M; Morishita E; Yamazaki M; Suga Y; Miyamoto KI; Nakao S
    Blood Coagul Fibrinolysis; 2001 Jun; 12(4):275-81. PubMed ID: 11460011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
    Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
    Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between biomarkers of endothelial injury and hypocoagulability in patients with severe sepsis: a prospective study.
    Ostrowski SR; Haase N; Müller RB; Møller MH; Pott FC; Perner A; Johansson PI
    Crit Care; 2015 Apr; 19(1):191. PubMed ID: 25907781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between sympathoadrenal activation, fibrinolysis, and endothelial damage in septic patients: a prospective study.
    Johansson PI; Haase N; Perner A; Ostrowski SR
    J Crit Care; 2014 Jun; 29(3):327-33. PubMed ID: 24581948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades.
    Biemond BJ; Levi M; Ten Cate H; Van der Poll T; Büller HR; Hack CE; Ten Cate JW
    Clin Sci (Lond); 1995 May; 88(5):587-94. PubMed ID: 7614818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemostatic and fibrinolytic indices in neonatal foals with presumed septicemia.
    Barton MH; Morris DD; Norton N; Prasse KW
    J Vet Intern Med; 1998; 12(1):26-35. PubMed ID: 9503357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.
    Di Bernardo MC; Matakidou A; Eisen T; Houlston RS;
    Lung Cancer; 2009 Aug; 65(2):237-41. PubMed ID: 19117638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.